Related Experiment Video
Updated: May 4, 2026
08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
19.0K
Definite familial multiple system atrophy with unknown genetics
Kyoko Itoh1, Takashi Kasai, Yukiko Tsuji
1Department of Pathology & Applied Neurobiology, Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Summary
This study reports two familial cases of Multiple System Atrophy (MSA), a neurodegenerative disorder. Despite extensive alpha-synuclein pathology, the genetic cause remains unknown, highlighting a gap in MSA genetic research.
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- Multiple System Atrophy (MSA) is typically sporadic, characterized by alpha-synuclein deposits and neurodegeneration.
- While rare Mendelian forms exist, the genetic basis for most MSA cases remains elusive.
- Understanding genetic factors is crucial for diagnosing and treating MSA.
Observation:
- Two familial cases of MSA were investigated, presenting with cerebellar and parkinsonian symptoms.
- Autopsies confirmed definite MSA with widespread alpha-synuclein deposition in glial and neuronal cells.
- The affected family showed no SNCA gene multiplication or COQ2 mutations.
Findings:
- Familial Multiple System Atrophy (MSA) can occur without identified genetic mutations in SNCA or COQ2.
- Extensive alpha-synuclein pathology was observed in both glial and neuronal cells, including cerebral cortices and hippocampus.
- The genetic underpinnings of these familial MSA cases remain undetermined.
Implications:
- These cases suggest potential novel genetic factors contributing to familial MSA.
- Further research is needed to elucidate the genetic architecture of MSA.
- Identifying genetic causes could lead to improved diagnostic tools and targeted therapies for MSA patients.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:21Huntington Disease l: Introduction
110
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21